Press Release October 9, 2021Indian Study Shows Merck's COVID-19 Antiviral Candidate Less Effective Against Moderate Infection: Reuters 0 0 Share
Company Ticker News October 9, 2021Two Indian drugmakers to end trials of generic Merck pill for moderate COVID-19 0 0 Share
Company Ticker News October 7, 2021Merck Staring Down Patent Cliff of Its Lucrative Cancer Wonder Drug 0 0 Share
Company Ticker News October 6, 2021Retail investors are dumping shares of COVID-19 vaccine makers and piling into antiviral pill maker Merck, data shows 0 0 Share
Company Ticker News October 6, 2021Merck's Oral COVID-19 Treatment Could Be Game-Changer: BofA Analyst 0 0 Share
